Maybe it is just me, but this offseason has come around quickly. We are into the New Year. Early drafts are taking place and ...

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announces the company’s ...